This review summarizes the clinical pharmacology, pharmacokinetics, and therapeutic application of beta-blockers in hypertension, highlighting their established role as first- or second-line antihypertensive agents.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Akio Ebihara (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: